3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
2
Pancreatic Adenocarcinoma
1
Multiple Myeloma
1
Metastatic Pancreatic Adenocarcinoma
1
Esophageal Neoplasms
1
Interventions
Fluorouracil
3
irinotecan sucrosofate
2
Leucovorin
2
zolbetuximab
1
pembrolizumab
1
beta-D-glucosylisophosphoramide mustard
1
Drug Therapy
1
4-fluorobenzoyl-TN-14003
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Metastatic Pancreatic Adenocarcinoma
×
4-fluorobenzoyl-TN-14003
×
Clear all
NCT02826486
2024-08-28
COMBAT
BioLineRx, Ltd.
Phase 2
Completed
80 enrolled
13 charts